Incyte Corporation (INCY) Covered Calls

Incyte Corporation is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

You can sell covered calls on Incyte Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INCY (prices last updated Fri 4:16 PM ET):

Incyte Corporation (INCY) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
75.87	-1.86	74.23	77.45	3.5M	555	15

Covered Calls For Incyte Corporation (INCY)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	75	4.60	72.85	3.0%	30.4%
Jan 17	75	4.70	72.75	3.1%	17.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	RKLB covered calls
3.	EEM covered calls	8.	KWEB covered calls	3.	LUNR covered calls
4.	FXI covered calls	9.	TLT covered calls	4.	NMRA covered calls
5.	IWM covered calls	10.	KRE covered calls	5.	CRVS covered calls

Want more examples? INCR Covered Calls | INDA Covered Calls